NeoGenomics (NEO)
NASDAQ:NEO
Holding NEO?
Track your performance easily

NeoGenomics (NEO) Technical Analysis

1,765 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
NeoGenomics’s (NEO) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting NeoGenomics is a Buy.
NeoGenomics’s (NEO) 20-Day exponential moving average is 16.14, while NeoGenomics’s (NEO) share price is $16.16, making it a Buy.
NeoGenomics’s (NEO) 50-Day exponential moving average is 15.79, while NeoGenomics’s (NEO) share price is $16.16, making it a Buy.

NeoGenomics (NEO) Pivot Points

Sep 20, 2024, 12:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.70
15.92
16.10
16.32
16.50
16.72
16.90
Fibonacci
15.92
16.07
16.16
16.32
16.47
16.56
16.72
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NeoGenomics (NEO) Moving Averages

Sep 20, 2024, 12:04 AM
Period
Simple
Exponential
MA5
16.28Sell
16.21Sell
MA10
16.07Buy
16.16Sell
MA20
16.18Sell
16.14Buy
MA50
15.92Buy
15.79Buy
MA100
14.99Buy
15.42Buy
MA200
15.47Buy
15.49Buy
NeoGenomics’s (NEO) 10-Day exponential moving average is 16.16, while NeoGenomics’s (NEO) share price is $16.16, making it a Sell.
NeoGenomics’s (NEO) 100-Day exponential moving average is 15.42, while NeoGenomics’s (NEO) share price is $16.16, making it a Buy.
NeoGenomics’s (NEO) stock price is $16.16 and NeoGenomics’s (NEO) 50-day simple moving average is 15.92, creating a Buy signal.
NeoGenomics’s (NEO) stock price is $16.16 and NeoGenomics’s (NEO) 100-day simple moving average is 14.99, creating a Buy signal.
NeoGenomics’s (NEO) stock price is $16.16 and NeoGenomics’s (NEO) 200-day simple moving average is 15.47, creating a Buy signal.

NeoGenomics (NEO) Technical Indicators

Sep 20, 2024, 12:04 AM
Name
Value
Implied Action
RSI (14)
50.98
Neutral
STOCH (9,6)
76.89
Neutral
STOCHRSI (14)
75.20
Neutral
MACD (12,26)
0.07
Buy
ADX (14)
14.64
Buy
Williams %R
-31.90
Buy
CCI (14)
30.94
Neutral
ATR (14)
0.61
-
Ultimate Oscillator
56.77
Neutral
ROC
-1.04
Sell
NeoGenomics’s (NEO) Relative Strength Index (RSI) is 50.98, creating a Neutral signal.
NeoGenomics’s (NEO) Trend Strength Indicator (ADX) is 14.64, creating a Buy signal.
NeoGenomics’s (NEO) Commodity Channel Index (CCI) is 30.94, creating a Neutral signal.
NeoGenomics’s (NEO) Price Rate of Change (ROC) is -1.04, creating a Sell signal.

FAQ

Is NEO a Buy, Hold, or Sell?
Based on NEO’s technical indicators, NEO is a Buy.
    What is NEO’s RSI (14)?
    NEO’s RSI (14) is 50.98, which suggests NEO is a Neutral.
      What is NEO’s MACD?
      NEO’s MACD is 0.07, which suggests NEO is a Buy.
        What is NEO’s 5-day moving average?
        NEO’s 5-day moving average is 16.28, which suggests NEO is a Sell.
          What is NEO’s 20-day moving average?
          NEO 20-day moving average is 16.18, which suggests NEO is a Sell.
            What is NEO’s 50-day moving average?
            NEO’s 50-day moving average is 15.92, which suggests NEO is a Buy.
              What is NEO’s 200-day moving average?
              NEO’s 200-day moving average is 15.47, which suggests NEO is a Buy.
                What is NEO’s Williams % R (14)?
                NEO’s Williams % R (14) is -31.90, which suggests NEO is a Buy.
                  What is NEO’s CCI (14)?
                  NEO’s CCI (14) is 30.94, which suggests NEO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis